Partner David Rosen spoke at American Conference Institute’s Legal and Regulatory Summit on Generic Drugs on July 18, 2013 in New York, NY. The panel Mr. Rosen presented was titled “Insights from the Office of Generic Drugs.”
For more information about the program, please visit the American Conference Institute Web site.
People
Related Insights
December 17, 2025
Foley Viewpoints
SEC and FINRA Increase Oversight of Cross-Border Small-Cap Offerings
Executive Summary In late 2025, the U.S. Securities and Exchange Commission (SEC) and the Financial Industry Regulatory Authority (FINRA)…
December 17, 2025
Foley Viewpoints
Amended Regulation S-P: Here to Stay and Being Examined in 2026
Last month, the U.S. Securities and Exchange Commission (SEC) Division of Examinations released its Fiscal Year 2026 “Examination…
December 17, 2025
Foley Viewpoints
It’s a Wonderful Hypo: What if the Bailey Bros. Building & Loan Was a SEC Registered Investment Adviser?
In the 1946 film “It’s a Wonderful Life,” George Bailey is despondent after a series of mishaps — including his family member and…